Analytical Data
-
基因名
FRYL
- Application
-
别名
ALL1-fused gene from chromosome 4p12 protein (AF4P12) (KIAA0826)
-
种属
Human
-
表达系统
Yeast
-
标签
C- His-Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O94915
-
表达区间
42-739aa
-
分子量
83.4
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FRYL (FOS-related protein with a YTH domain) is a recently identified protein that has garnered attention in the field of molecular biology due to its role in cellular processes such as cell differentiation, proliferation, and apoptosis. As a member of the FOS family of proteins, FRYL plays a critical role in regulating gene expression and has been implicated in various physiological and pathological conditions, including cancer. Its unique YTH domain allows it to interact with RNA methylation, suggesting a potential link between epitranscriptomics and cellular signaling pathways. Research into FRYL has unveiled its importance in developmental biology, particularly in neural and skeletal system development. Moreover, studies have indicated that dysregulation of FRYL may contribute to malignancies, making it a potential target for therapeutic intervention. Understanding the functional role and regulatory mechanisms of FRYL could provide valuable insights into its involvement in disease and pave the way for novel treatment strategies. Animal models and advanced genomic techniques are being utilized to elucidate the biological significance of FRYL and its interactions within various cellular contexts, highlighting the need for comprehensive studies to fully unravel its complex roles in health and disease. This investigation into FRYL represents a growing interest in how epitranscriptomic modifications can influence cellular behavior, reflecting a broader trend in biomedical research focusing on non-coding RNAs and their associated regulatory proteins. As the research community continues to explore FRYL's functional implications, it holds the potential to significantly advance our understanding of gene regulation and cell dynamics, ultimately leading to innovative approaches in treating diseases where these processes are disrupted.












